ArticleJAMA oncology2018

Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials.

Aziz Zaanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.